Lonza primary immune cells and media

Friday, 11 June, 2010 | Supplied by: Capsugel Australia Pty Ltd

Lonza primary immune cells and media

Lonza supplies a variety of primary cells isolated from normal peripheral blood, cord blood and bone marrow along with media specifically developed for culturing primary immune cells.

Cells are available to fit specific experimental needs, with a large selection of donors and lots and multiple immune cell types are available from the same donor.

Cells are processed to ensure highly homogeneous populations with high purity (≥85%) and viabilities of 100% of the stated cell number per product label.

Primary cells include: CD41+ monocytes, CD4+ T-cells, CD19+ B-cells, dendritic cells, NK cells, mononuclear cells.

LGM-3 Lymphocyte Growth Medium-3 was developed for the growth and support of human lymphocytes and dendritic cells.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

Amsbio validated cytokines for organoid culture

Amsbio has launched over a range of over 30 independently developed and manufactured organoid...

Dendritics monoclonal antibodies for dendritic cell research

Dendritics' mouse and rat antibodies are logically grouped into several product families: DC...

Bioss In Vivo Biosimilar Antibodies

Bioss In Vivo Biosimilar Antibodies are research-grade copies of therapeutic antibodies that are...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd